| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Atorvastatin | FAERS: 7 | US FAERS | |
| 2 | Doxorubicin | FAERS: 3 | US FAERS | |
| 3 | Imiquimod | FAERS: 2 | US FAERS | |
| 4 | NuvaRing | FAERS: 2 | US FAERS | |
| 5 | Ondansetron | FAERS: 2 | US FAERS | |
| 6 | Cetirizine | FAERS: 1 | US FAERS | |
| 7 | Dimethyl Fumarate | FAERS: 1 | US FAERS | |
| 8 | Testosterone | FAERS: 1 | US FAERS | |
| 9 | chloroquine diphosphate | FAERS: 1 | US FAERS | |
| 10 | liposomal doxorubicin | FAERS: 1 | US FAERS | |
| 11 | Cytarabine | OFFSIDES | ||
| 12 | Daunorubicin | OFFSIDES | ||
| 13 | Mercaptopurine | OFFSIDES | ||
| 14 | Thioguanine | OFFSIDES | ||
| 15 | azelastine | OFFSIDES | ||
| 16 | ferrous fumarate | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120266
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.